Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Bladder Cancer|Breast Cancer|Carcinoma of Unknown Primary|Esophageal Cancer|Gastric Cancer|Head and Neck Cancer|Lung Cancer|Melanoma (Skin)|Ovarian Cancer|Pancreatic Cancer|Prostate Cancer|Sarcoma
Interventions: BIOLOGICAL: filgrastim|DRUG: docetaxel|DRUG: gemcitabine hydrochloride
Sponsor: Dartmouth-Hitchcock Medical Center
Collaborators: National Cancer Institute (NCI)